Brief: Wockhardt Says Zaynich Achieves Over 97% Efficacy In Clinical Study
13/01/2025 03:35
Jan 13 (Reuters) - Wockhardt Ltd WCKH.NS :
* WOCKHARDT LTD - ZAYNICH ACHIEVES OVER 97% EFFICACY IN
CLINICAL
STUDY
Source text: ID:nNSE47dchr
Further company coverage: WCKH.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on Wockhardt
See all newsBrief: Wockhardt Says Customs Authority Imposes 50 Million Rupees Penalty And 100 Million Rupees Redemption Fine On Co
Brief: Wockhardt Limited June-Quarter Consol Net Profit 1.06 Billion Rupees
India's Wockhardt gains after marketing authorization for antibiotic ZAYNICH
Brief: Wockhardt Says Indian Drug Regulator Grants Marketing Authorization To Co's Zaynich
India's Wockhardt hits 7‑month high after swinging to profit in fourth quarter